8-K: IFF Reports Mixed Q4 and Full Year 2023 Results, Announces Dividend Cut

International Flavors & Fragrances Inc. reported a net loss for both the fourth quarter and full year 2023, driven by a significant goodwill impairment, while also showing some positive trends in adjusted operating EBITDA and sales growth in certain segments.

Summary

• International Flavors & Fragrances Inc. (IFF) announced its financial results for the fourth quarter and full year ended December 31, 2023.
• The company reported a net loss of $2.61 billion for the fourth quarter and $2.57 billion for the full year, primarily due to a $2.6 billion non-cash goodwill impairment charge.
• Reported sales for the fourth quarter were $2.70 billion, a 5% decrease compared to the prior year, but comparable currency neutral sales increased by 1%.
• For the full year, reported sales were $11.48 billion, an 8% decrease year-over-year, while comparable currency neutral sales decreased by 1%.
• Adjusted operating EBITDA for the fourth quarter was $461 million, with a 17% increase on a comparable currency neutral basis.
• Full year adjusted operating EBITDA was $1.98 billion, a 10% decrease on a comparable currency neutral basis.
• The company has updated its dividend policy, reducing the quarterly dividend by approximately 50% to $0.40 per share to enable faster deleveraging.
• IFF expects full year 2024 sales to be between $10.8 billion and $11.1 billion and adjusted operating EBITDA to be between $1.9 billion and $2.1 billion.

Sentiment

Score: 4

Explanation: The sentiment is negative due to the significant net loss and goodwill impairment, although there are some positive aspects such as improved adjusted operating EBITDA and sales growth in certain segments. The dividend cut also contributes to the negative sentiment.

Positives

• Comparable currency neutral sales increased by 1% in the fourth quarter, indicating underlying growth.
• Adjusted operating EBITDA saw a significant 17% increase on a comparable currency neutral basis in the fourth quarter.
• The Scent and Health & Biosciences segments showed strong growth in sales and adjusted operating EBITDA.
• Volume performance improved sequentially across nearly all businesses.
• The company is taking steps to improve its financial flexibility by reducing the dividend and focusing on deleveraging.

Negatives

• The company reported a substantial net loss of $2.61 billion for the fourth quarter and $2.57 billion for the full year.
• Reported sales decreased by 5% in the fourth quarter and 8% for the full year.
• The Nourish and Pharma Solutions segments experienced sales declines.
• Full year adjusted operating EBITDA decreased by 10% on a comparable currency neutral basis.
• The company recorded a $2.6 billion non-cash goodwill impairment charge, primarily impacting the Nourish segment.
• Pricing is expected to decline approximately 2.5% in 2024.

Risks

• The company faces continued macroeconomic uncertainty, which could impact future performance.
• There are risks associated with the integration of the N&B business and the ability to realize expected benefits.
• The company has a substantial amount of indebtedness, which could affect liquidity and credit ratings.
• The company is exposed to risks related to supply chain disruptions, geopolitical developments, and climate change.
• There are risks associated with the company's ability to compete effectively and develop new products.
• The company is exposed to currency fluctuations and economic risks associated with international operations.

Future Outlook

The company expects full year 2024 sales to be in the range of $10.8 billion to $11.1 billion and adjusted operating EBITDA to be in the range of $1.9 billion to $2.1 billion. Volume is expected to grow 0% to 3%, while pricing is expected to decline approximately 2.5%. Comparable currency neutral adjusted operating EBITDA is expected to grow 3% to 11%.

Management Comments

• IFF CEO Erik Fyrwald stated he is thrilled to join IFF at such an important and dynamic time.
• He noted that IFF delivered solid results in the fourth quarter, including a sequential improvement in volume and double-digit adjusted operating EBITDA growth on a comparable currency neutral basis.
• Management updated the dividend policy to enable faster deleveraging and provide improved financial flexibility.
• Management is cautiously optimistic that they can deliver improved financial results for shareholders in 2024.

Industry Context

The announcement reflects the challenges faced by the flavors and fragrances industry, including macroeconomic uncertainty, supply chain disruptions, and inflationary pressures. The company's focus on deleveraging and cost management aligns with broader industry trends of optimizing operations and improving financial stability. The mixed results highlight the varying performance across different segments, which is common in diversified companies within this sector.

Comparison to Industry Standards

• IFF's performance is mixed when compared to industry peers. While some companies have shown resilience in sales growth, others have faced similar challenges with profitability and cost management.
• For example, Givaudan, a major competitor, has also reported mixed results, with some segments performing better than others. However, Givaudan has not had to take a goodwill impairment of this magnitude.
• Symrise, another competitor, has focused on innovation and sustainability, which has helped them maintain a stronger position in the market. IFF's focus on deleveraging and cost management is a response to the current economic environment, similar to actions taken by other companies in the sector.
• The 4.5x net debt to credit-adjusted EBITDA ratio is higher than some competitors, indicating a need for IFF to focus on debt reduction. Companies like Firmenich have a lower leverage ratio, which provides them with more financial flexibility.

Corporate Governance

Stakeholder Impact

• Shareholders will experience a reduction in dividend payments, but the company aims to improve long-term financial health.
• Employees may be affected by restructuring and cost-cutting measures.
• Customers may see changes in pricing and product offerings as the company optimizes its portfolio.
• Creditors will be impacted by the company's efforts to deleverage and improve its financial position.
• Suppliers may be affected by changes in the company's procurement strategies.

Next Steps

• The company will hold a live webcast on February 21, 2024, to discuss the financial results.
• The company will focus on deleveraging the balance sheet and improving financial flexibility.
• The company will continue to implement its refreshed growth-focused strategy.
• The company will release its Annual Report on Form 10-K by February 29, 2024.

Key Dates

Keywords

financial results, operating EBITDA, sales, goodwill impairment, dividend policy, deleveraging, currency neutral, net loss, IFF, fragrances, flavors, biosciences